Sponsor Pipeline

Yang Hong Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06598527 Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy… Lung Cancer (NSCLC) Recruiting
Phase 2
NCT07309952 Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC Locally Advanced Non-Small Cell Lung Cancer Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2)
Get alerts when Yang Hong's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free